New studies shed light on infection risk factors, role of hematomas
International study finds 94.6% success for scheduled transmissions, good patient acceptance
NIH grant bolsters research to refine choice of ablation candidates and targets
Pilot study supports feasibility when paired with a cloud-based platform
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement